Home > Boards > US OTC > Medical - Equipment >

SpectraSCIENCE, Inc. (SCIE)

SCIE RSS Feed
Add SCIE Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, SANDRA11
Search This Board: 
Last Post: 5/23/2019 8:06:01 PM - Followers: 207 - Board type: Free - Posts Today: 0

Spectra Science - Innovations In Cancer Detection

SCIE Will Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA and plan for additional clinical trials to support eventual approval for sale in the United States !!
 
Lighting the way to improve your practice.

The proprietary WavSTAT Optical Biopsy System assists the practicing gastroenterologist who uses a flexible endoscope to find polyps that may be cancerous. The capability to distinguish if the tissue is cancerous or not is made immediately, and complements your expertise. The physician uses laser-induced fluorescence and an optical fiber to transmit laser light via the flexible endoscope to the tissue. The auto-fluorescence from the tissue is then collected and returned to an optical detector for analysis. The result is then available with no waiting days for a pathology report.

Simply stated, we work with you to create better outcomes for your patients.


Our value proposition is simple

We improve a doctor's ability to diagnose cancer
and we lower the cost of diagnosis.

SpectraScience offers a simplified yet highly effective way of diagnosing colorectal cancer early, when recovery rates are high. Our WavSTAT Optical Biopsy System® uses light to diagnose tissue health. In fact, our patented technology instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy.

According to the American Cancer Society, over 140,000 new cases of colorectal cancer are expected in the US this year alone. This dreaded disease is the second leading cause of cancer-related deaths in the US (after lung cancer), and the third most common cancer overall. Only 39% of colorectal cancers are detected at an early stage.

Products

Our proprietary WavSTAT Optical Biopsy System is used as an adjunct to the gastroenterologist in normal practice and is compatible with existing endoscopes. The WavSTAT uses Laser Induced Fluorescence and an optical fiber forceps to transmit laser light via endoscope to the tissue. Auto-fluorescence back from the interrogated tissue is collected and returned to an optical detector for analysis and a definitive diagnostic rendered. The WavSTAT provides a binary, "Suspect" or "Non-Suspect" diagnostic output which, unlike traditional image-based systems, requires no analysis or interpretation.


Technology
 

Laser-Induced Fluorescence Spectroscopy (LIF)

The WavSTAT Optical Biopsy System is presently based upon technology that detects the native fluorescence of tissue. Fluorescence occurs when various molecular components present in tissue are “excited” at certain wavelengths of light and re-emit energy in a distinct and measurable way. This re-emitted energy is referred to as the spectral signature. Healthy tissue generates a spectral signature that is measurably different from tissue that is not normal, such as cancerous and pre-cancerous tissue. LIF targets these chemical properties of tissue: amino acids, enzymes, and structural proteins.

Scattering Spectroscopy (SS)

This IP-protected technology is a novel optical scientific method that will complement our LIF technology in future WavSTAT Systems. It can be used in combination with LIF or stand-alone for diagnosis. SS targets physical properties of tissue: vascularity, epithelial thickness and cell nuclei.

SS employs a wavelength-dependent component of light scattered by epithelial cells to obtain information about subcellular structures, such as cell nuclei. Since nuclear atypia is one of the hallmarks of precancerous and cancerous changes in most human tissues, the technique has the potential to provide a broadly applicable means of detecting epithelial precancerous lesions and noninvasive cancers in various organs*. These can be optically accessed either directly or by means of optical fibers. Therefore, SS facilitates the ability to scan the tissue and detect, not merely diagnose, possible cancerous lesions.
*Citable URI: http://hdl.handle.net/1721.1/29892

Multi Modal

In the future, we envision a combination of LIF and SS will provide a blend of light-based diagnoses for optimal clinical results across many different kinds of cancer. We believe that this “multi-modal” future will allow us to pursue many detection and diagnosis markets, with an increased number of possible strat

The WavSTAT mobile console is the heart of the system and is comprised of a low-power laser, a sophisticated light detector, an internal computer and analysis software. The console incorporates a touch screen for input and output as well as the capability of interfacing with additional screens providing, for example, an image which can be included on a typical endoscope monitor. The key to the diagnostic process is our proprietary waveform analysis algorithm. used today to diagnose colon cancer and precancerous tissue.
 

SpectraScience, Inc

Most Recent Financials

DownloadViewX
Filed Date Form Type Description View
05/22/2017 Form 10-Q Quarterly report
05/15/2017 Form NT 10-Q Notification of inability to timely Form 10-Q
       
       
       
       
       
       
       
       
       
       
    Partial List of Company Owned PATENTS:
Referenced by
Citing Patent Filing date Publication date Applicant Title
WO1999045838A1 * Mar 9, 1999 Sep 16, 1999 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
EP2018824A1 * Mar 9, 1999 Jan 28, 2009 Spectrascience, Inc. Optisches Biopsiesystem und Verfahren zur Gewebediagnose
US6066102 * Mar 9, 1998 May 23, 2000 Spectrascience, Inc. Optical biopsy forceps system and method of diagnosing tissue
US6174291 * Mar 9, 1998 Jan 16, 2001 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
 
       
       

about

You are here: about / management

Management

Michael P. Oliver     President and Chief Executive Officer

Mr. Oliver, has more than 20 years of experience in the medical device industry, and has been a member of four separate management teams that took over struggling medical device companies, increased their revenues and profitability and sold them to strategic buyers. In these companies Mr. Oliver served in the capacity of head of sales and marketing, and, in two cases held major operational responsibilities as well. Mr. Oliver received his MSA from George Washington University and his BS from the United States Naval Academy.

Lowell Giffhorn     Chief Financial Officer

Lowell Giffhorn, CFO, joined the Company in September 2013.  Mr. Giffhorn brings to the Company more than 20 years of senior management experience in finance, operations, planning and and strategic planning. Prior to joining SpectraScience, Mr. Giffhorn was Chief Financial Officer of Patriot Scientific and Sym-Tek systems, both micro-cap public companies.  He was instrumental in helping to raise more than $20 million in public equity.  Mr. Giffhorn practiced as a Certified Public Accountant with Arthur Young (Ernst and Young) and holds an MBA and a BS in Accounting from the University of Illinois.

Hughes Wielemans     Director of Business Development - Europe

Mr. Wielemans has over 20 years of experience in sales, marketing and management while working for multi-national medical device companies and distributors in Europe.Most recently, he was the Director of Sales and Marketing for USGI Medical, Ltd. in Europe. Prior to this he was the Country Manager for Bariatric Solutions Gmbh in Belgium. Mr. Wielemans spent three years as the Director of Sales & Marketing for Covidien Belgium. Before this he worked as European Product Director and Manager for six years with Tyco Healthcare. Mr. Wielemans attended the Institut Catholique des Hautes Etudes Commerciales, Brussels, Sciences Economiques. 

Mike Brady      Director of Engineering

Most recently Mr. Brady spent three years as a Senior Project Manager/ Systems Engineer. Prior to this he spent three years at Elgar Electronics where he managed several concurrent engineering projects. Before this, Mr. Brady spent thirteen years at leading medical device manufacturer Mallinckrodt/Nellcor Puritan Bennet, where he was a Senior Project Manger/Principal Electronic Engineer. Brady holds a BSEE degree from San Diego State University.

Todd Pinkowski     Director of Operations

Mr. Pinkowski brings over 23 years of extensive operations and production experience to the Company. Prior to SpectraScience, Inc. Mr. Pinkowski spent nine years with ResMed Corp. as Senior Manager of Technical Service and Manufacturing. Before this he spent 14 years as a Senior Production Supervisor with Infrasonics/Nellcor PB. Mr. Pinkowski began his career as an Aircraft Armament Systems Specialist with the U.S. Air Force.

 

Wells Fargo Shareholder Services (Minneapolis, MN) 


Transfer Agent 
1110 Centre Pointe Curve
Suite 101
St. Paul, MN 55120
800-468-9716
http://www.wellsfargo.com
stocktransfer@wellsfargo.com
 
SCIE Security Details
Share Structure
  Market Value1 $432,096 a/o Jul 21, 2017
  Authorized Shares 6 Billion
https://mblsportal.sos.state.mn.us/Business/SearchDetails?filingGuid=b10baf74-a2d4-e011-a886-001ec94ffe7f
  Outstanding Shares 2,685,830,579. August 14, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.01


 
Contact
  • 11568 Sorrento Valley Rd # 11
    San Diego, CA 92121
    Telephone: 858-847-0200
    Email: info@spectrascience.com
    Directions: Click
     
 
Update with SpectraScience, Inc.- Medical Device Company Discusses 2016 Corporate Developments
http://stocknewsnow.com/commentary/ANEWSID05062016100001/SNNLive-Update-SpectraScience-Inc-(OTC-PINK-SCIE)

 
SCIE
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#10802  Sticky Note Must Read: XenaLives 04/25/16 02:10:18 PM
#24694   This will run to 00 before the split. Better SANDRA11 05/23/19 08:06:01 PM
#24693   Welcome back. Where is that news you promised SANDRA11 05/18/19 12:01:20 PM
#24692   https://otcshortreport.com/company/SCIE SANDRA11 05/18/19 11:59:40 AM
#24691   Why ask her, she doesn't have a clue! wanna be 05/17/19 03:27:20 PM
#24690   1 for 1000/ 10000 SANDRA11 05/17/19 06:16:23 AM
#24689   SandraII--In what range do you think been-32yr 05/17/19 12:47:24 AM
#24688   We will agree to disagree for now, Till I SANDRA11 05/16/19 02:55:49 PM
#24687   I disagree, won't R/S and won't run. XenaLives 05/16/19 02:45:14 PM
#24686   LMAO. This will run eventually. One last time. SANDRA11 05/16/19 02:42:16 PM
#24685   Who is buying 15MM+ shares of this crap? lovindollars 05/16/19 02:38:16 PM
#24684   Last trades were at .0001 yet they are SANDRA11 05/15/19 05:22:17 PM
#24683   I am confident that one day out of SANDRA11 05/15/19 10:27:05 AM
#24682   I think that he is in a dispute SANDRA11 05/14/19 06:17:22 PM
#24681   We should sue him for every last thin dime. lovindollars 05/14/19 04:05:03 PM
#24680   3,000,000.00 SANDRA11 05/09/19 04:43:50 PM
#24679   How much do you think the CEO has Liveingreenbay 05/09/19 03:02:03 PM
#24678   Yes. SANDRA11 05/09/19 01:58:14 PM
#24677   Sandra: Are you still using the stock in been-32yr 05/09/19 03:42:46 AM
#24676   100 percent shares sold yesterday were short Shares. SANDRA11 04/19/19 09:39:16 AM
#24675   SEC Has a link on their websight that SANDRA11 04/19/19 08:17:16 AM
#24674   Funny. TGD would be in line first. N2deep1 04/18/19 09:25:38 PM
#24673   SEC is as useless as tits on a SANDRA11 04/18/19 07:42:44 PM
#24672   Agreed, but jail time should be mandatory. XenaLives 04/18/19 07:36:15 PM
#24671   This IDIOT Olie should be banned for life SANDRA11 04/18/19 07:10:51 PM
#24670   I will just link this here for anyone lovindollars 04/18/19 05:03:55 PM
#24669   THANK YOU!!!!! lovindollars 04/18/19 04:01:16 PM
#24668   How is this still traded. Close the co 24jg 04/16/19 10:48:22 PM
#24667   Every share traded in the past few weeks, SANDRA11 04/16/19 09:53:04 AM
#24666   To my point on the previous post. 602000 shares SANDRA11 04/14/19 08:45:33 AM
#24665   Here Are Some Facts, The company can't issue more shares, Till they SANDRA11 04/07/19 07:07:32 AM
#24664   Gee, some one bought 10 cents worth today! They SANDRA11 04/04/19 07:14:24 PM
#24663   It will shoot up real quick when it does SANDRA11 04/01/19 11:25:36 AM
#24662   SCIE 0.0001 - BUY trader53 04/01/19 06:44:14 AM
#24661   Oh, What happened to the news you promised SANDRA11 03/29/19 03:10:58 PM
#24660   Come on! Have you ever tried to short wanna be 03/29/19 12:19:20 PM
#24659   I was dead on, The entire 50 million SANDRA11 03/28/19 06:57:59 AM
#24658   Who's trying to sell 50m @ .0001. LOLOLOLOL mackie1 03/27/19 08:17:54 PM
#24657   Yeah cording to that data we should have SANDRA11 03/27/19 01:01:29 PM
#24656   No way to know. I don't XenaLives 03/27/19 12:54:44 PM
#24655   Was this trade today, wash trading? SANDRA11 03/27/19 11:18:22 AM
#24654   At some point, We will see filling, Or SANDRA11 03/21/19 09:27:10 AM
#24653   I was going through your history trying to deadjim 03/21/19 01:01:53 AM
#24652   There are lots of companies in pinki land SANDRA11 03/20/19 06:44:36 AM
#24651   I doubt it. SANDRA11 03/11/19 08:53:20 AM
#24650   OTC short report specializes in confusing investors. XenaLives 03/11/19 07:28:27 AM
#24649   According to otc short report about 99 percent SANDRA11 03/06/19 11:00:45 AM
#24648   FYI, I have seen gray market stocks make SANDRA11 02/22/19 07:07:57 AM
#24647   Yeah so? Pugilista 02/21/19 06:09:36 PM
#24646   That tells me a lot about you. Liveingreenbay 02/21/19 05:20:48 PM
#24645   which ever one you will fall for LMAO! Pugilista 02/21/19 11:44:11 AM
PostSubject